Histone Deacetylase Inhibitor VI, HNHA
CAS: 926908-04-5
Ref. 3D-BMB90804
| 5mg | Discontinued | ||
| 10mg | Discontinued | ||
| 25mg | Discontinued | ||
| 50mg | Discontinued | ||
| 100mg | Discontinued |
Product Information
Name:
Histone Deacetylase Inhibitor VI, HNHA
Synonyms:
- N-hydroxy-7-(2-naphthylthio)heptanamide
Description:
Histone Deacetylase Inhibitor VI, HNHA is a synthetic compound that inhibits histone deacetylases. It has potent antitumor activity and antiangiogenic properties. HNHA blocks the activity of dna methyltransferase and prevents the transfer of acetyl groups to lysine residues on histones, leading to gene silencing and cell death. HNHA also binds to HIV-1 integrase and has been shown to be active against leukemia cells in vitro. The mechanism of action for HNHA is not fully understood but may involve hydrogen bonding or fatty acid binding.
Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Biosynth
Long term storage:
Notes:
Chemical properties
Molecular weight:
303.42 g/mol
Formula:
C17H21NO2S
Purity:
Min. 95%
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:
